The Procter & Gamble Company (PG) SEC Filings & Earnings Calls
EquiReason read 24 The Procter & Gamble Company SEC filings in the last 12 months. Latest: 10-Q on 2026-10-22 — P&G reported Q1 fiscal 2027 net sales of $23.3B (+4% YoY), diluted EPS of $1.97 (+1%), and gross margin contraction of 160 bps..
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
- Market cap
- 373.2B
- P/E TTM
- 24.3
- Dividend yield
- 2.7%
- 52-week
- —
- Next earnings
- 20 Jan, in 88 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
22 Oct 202610-QP&G reported Q1 fiscal 2027 net sales of $23.3B (+4% YoY), diluted EPS of $1.97 (+1%), and gross margin contraction of 160 bps.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q1-2027 | $23.28B | +4% y/y |
| Diluted EPS · Q1-2027 | $1.97 | +1% y/y |
| Core EPS · Q1-2027 | $2.00 | +1% y/y |
| Operating cash flow · Q1-2027 | $5.80B | +7% y/y |
| Free cash flow · Q1-2027 | $4.40B | |
| Gross margin · Q1-2027 | 49.8% |
Risks flagged
Commodity cost inflation
“The decrease in gross margin was due to: 140 basis points of higher commodity costs” · word for word
Restructuring execution risk
“The Company expects to incur approximately $2.0 billion in before-tax restructuring costs over a two-year period.”
Foreign exchange exposure
“We have significant exposure to exchange rate fluctuations, both due to translation and transaction exposures.” · word for word
22 Oct 20268-K · 2.02PG reported Q1 FY2027 net sales of $23.3B (+4% YoY), diluted EPS $1.97 (+1%), core EPS $2.00 (+1%). Organic sales +4%. Maintained FY organic sales, EPS growth and cash return guidance. Gross margin down 150bps on commodity costs and reinvesearningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q1-2027 | $23.30B | +4% y/y |
| Diluted EPS · Q1-2027 | $1.97 | +1% y/y |
| Core EPS · Q1-2027 | $2.00 | +1% y/y |
| Operating Cash Flow · Q1-2027 | $5.80B | |
| Free Cash Flow Productivity · Q1-2027 | 93.0% | |
| Net Earnings · Q1-2027 | $4.80B | |
| Dividend Payments · Q1-2027 | $2.60B | |
| Share Repurchases · Q1-2027 | $1.30B | |
| Core Gross Margin Change · Q1-2027 | -150.0% |
Guidance
Maintains fiscal year organic sales growth, core EPS growth and free cash flow productivity guidance; updates net sales guidance for Thorne acquisition.
PG reaffirmed its FY2027 organic sales, core EPS growth and free cash flow productivity guidance, indicating confidence in the near term despite margin pressure.
Risks flagged
Commodity cost inflation pressuring gross margin
“140 basis points of higher costs from commodities” · word for word
Product reinvestments weighing on margins
“140 basis points of product reinvestments” · word for word
22 Oct 20268-K · 7.01PG reports Q1 FY2027 organic sales +4.0%, core EPS $2.00 (+1% YoY), maintains FY2027 guidance: organic sales +1-3%, core EPS growth +0-3%. Macro headwinds noted but topline accelerating.earningsopen
Figures in the filing · each found in the filing text
| Organic Sales Growth · Q1-2027 | 4.0% | |
| Organic Volume Growth · Q1-2027 | 2.4% | |
| Core Earnings Per Share · Q1-2027 | $2.00 | +1% y/y |
| Free Cash Flow Productivity · Q1-2027 | 93.0% | |
| Core Gross Margin ex-FX Change · Q1-2027 | -150.0% | |
| Core Operating Margin ex-FX Change · Q1-2027 | -90.0% | |
| Beauty Organic Sales Growth · Beauty · Q1-2027 | 5.4% | |
| Grooming Organic Sales Growth · Grooming · Q1-2027 | 4.5% | |
| Health Care Organic Sales Growth · Health Care · Q1-2027 | 2.7% | |
| Fabric & Home Care Organic Sales Growth · Fabric & Home Care · Q1-2027 | 4.8% |
Guidance
FY27 organic sales growth +1% to +3% (maintained); net sales growth +2% to +4% (updated); core EPS growth +0% to +3% (maintained); all-in EPS growth +1% to +5% (maintained); currency-neutral core EPS growth +0% to +3%; core effective tax rate 20-21%; free cash flow productivity 85-90%; capital spending 4.5-5.5% of sales; dividends >$10bn; direct share repurchase ~$5bn
PG maintains FY2027 guidance despite macro headwinds, with topline acceleration but margin pressure from commodity costs and FX.
Risks flagged
Commodity cost headwinds: $1.4Bn after-tax impact from higher energy, transportation, and raw material costs
“$1.4Bn after-tax impact from higher energy, transportation, and raw material costs” · word for word
Foreign exchange headwind: $50MM after-tax headwind
“$50MM after-tax headwind from foreign exchange” · word for word
Higher net interest expense: $300MM after-tax headwind
“$300MM after-tax of higher net interest expense” · word for word
Lower non-operating income: $150MM after-tax headwind
“$150MM after-tax of lower non-operating income” · word for word
13 Oct 20268-K · 7.01PG declares a routine quarterly dividend of $1.0885 per share, consistent with prior quarters; no change in dividend policy or special dividend.open
Figures in the filing · each found in the filing text
| quarterly dividend per share · Q2-2026 | $1.09 |
28 Aug 2026DEF 14ACEO transition completed: Shailesh Jejurikar became President and CEO on January 1, 2026, and was appointed Chairman of the Board effective August 1, 2026, following Jon Moeller's retirement.open
Figures in the filing · each found in the filing text
| Organic Sales Growth · FY2026 | 1.4% | |
| Core EPS Growth · FY2026 | 0.9% |
4 Aug 202610-KP&G reported FY2026 results with 3% net sales growth, announced a restructuring plan including up to 7,000 job cuts, and agreed to acquire Thorne for $3.8B.open
Figures in the filing · each found in the filing text
| Net sales · FY2026 | $87.03B | +3% y/y |
| Net earnings attributable to Procter & Gamble · FY2026 | $16.05B | +0% y/y |
| Diluted net earnings per common share · FY2026 | $6.62 | +2% y/y |
| Core earnings per share · FY2026 | $6.89 | +1% y/y |
| Cash flow from operating activities · FY2026 | $19.56B | +10% y/y |
| Adjusted free cash flow · FY2026 | $15.80B | |
| Organic sales growth · FY2026 | 1.0% | |
| Employees · FY2026 | 104,000 | -4% y/y |
Risks flagged
Restructuring execution risk
“The Company expects to incur approximately $1.5 to $2.0 billion in before-tax restructuring costs over a two-year period.” · word for word
Foreign exchange exposure
“We have significant exposure to exchange rate fluctuations, both due to translation and transaction exposures.” · word for word
Commodity cost volatility
“We have significant exposures to certain commodities and input materials, in particular certain oil-derived materials like resins and paper-based materials like pulp.” · word for word
Tariff uncertainty
“The Company previously paid approximately $200 million in IEEPA tariffs that may be recoverable.” · word for word
29 Jul 20268-K · 2.02Net sales $87.00B (+3% y/y); Diluted EPS $6.62 (+2% y/y); Core EPS $6.89 (+1% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net sales · FY2026 | $87.00B | +3% y/y |
| Diluted EPS · FY2026 | $6.62 | +2% y/y |
| Core EPS · FY2026 | $6.89 | +1% y/y |
| Operating cash flow · FY2026 | $19.60B | |
| Net earnings · FY2026 | $16.10B | |
| Adjusted free cash flow productivity · FY2026 | 100.0% | |
| Dividend payments · FY2026 | $10.20B | |
| Share repurchases · FY2026 | $5.00B |
Risks flagged
Core gross margin contracted 40bps and core operating margin 70bps, indicating cost pressures.
“Core gross margin -40 basis points; Core operating margin -70 basis points”
29 Jul 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Combining CEO and Chairman roles may reduce board independence, but orderly transition mitigates disruption risk.
“Jejurikar assumes the position in addition to his role as President and Chief Executive Officer.” · word for word
29 Jul 20268-K · 7.01Net sales $87.00B (+3% y/y); Diluted EPS $6.62 (+2% y/y); Core EPS $6.89 (+1% y/y); Guidance: FY2027 organic sales growth +1-3%, core EPS growth +0-3%open
Figures in the filing · each found in the filing text
| Net sales · FY2026 | $87.00B | +3% y/y |
| Diluted EPS · FY2026 | $6.62 | +2% y/y |
| Core EPS · FY2026 | $6.89 | +1% y/y |
| Organic sales growth · FY2026 | 1.0% | |
| Operating cash flow · FY2026 | $19.60B | |
| Adjusted free cash flow productivity · FY2026 | 100.0% | |
| Dividend payments · FY2026 | $10.20B | |
| Share repurchases · FY2026 | $5.00B |
Guidance
FY2027 organic sales growth +1-3%, core EPS growth +0-3%
Guidance reflects significant cost headwinds and modest growth expectations; Q1 EPS expected to decline 5% or more.
Risks flagged
Higher energy, transportation, and raw material costs creating $1B after-tax headwind in FY2027.
“$1Bn after-tax impact from higher energy, transportation, and raw material costs” · word for word
Foreign exchange and higher net interest expense adding $200M after-tax headwinds.
“$50MM after-tax headwind from foreign exchange; $150MM after-tax of higher net interest expense” · word for word
14 Jul 20268-K · 7.01Dividend per share $1.09open
Figures in the filing · each found in the filing text
| dividend_per_share · Q4-2026 | $1.09 |
24 Apr 20268-K · 2.02Net Sales $21.20B (+7% y/y); Diluted EPS $1.63 (+6% y/y); Core EPS $1.59 (+3% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q3-2026 | $21.20B | +7% y/y |
| Diluted EPS · Q3-2026 | $1.63 | +6% y/y |
| Core EPS · Q3-2026 | $1.59 | +3% y/y |
| Operating Cash Flow · Q3-2026 | $4.00B | |
| Adjusted Free Cash Flow Productivity · Q3-2026 | 82.0% | |
| Dividends Paid · Q3-2026 | $2.50B | |
| Share Repurchases · Q3-2026 | $600M |
Guidance
Maintained FY2026 guidance: organic sales growth 0-4%, core EPS growth 0-4%, adjusted FCF productivity 85-90%, capex 4-5% of sales. Management cites 'challenging geopolitical and economic environment' but sees momentum.
Risks flagged
Tariff cost headwinds and commodity cost increases pressuring margins.
“50 bps tariff cost impact on gross margin; 10 bps commodity cost increase.”
Unfavorable product mix impacting gross margin.
“180 bps unfavorable mix impact on core gross margin.”
24 Apr 20268-K · 7.01Organic Sales Growth 3; Organic Volume Growth 2; Core EPS $1.59 (+3% y/y); Guidance: Organic Sales Growth: +0% to +4%; Core EPS Growth: +0% to +4%open
Figures in the filing · each found in the filing text
| Organic Sales Growth · Q3-2026 | 3.0% | |
| Organic Volume Growth · Q3-2026 | 2.0% | |
| Core EPS · Q3-2026 | $1.59 | +3% y/y |
| Adjusted Free Cash Flow Productivity · Q3-2026 | 82.0% | |
| Core Gross Margin Change · Q3-2026 | -100.0% | |
| Net Sales · Q3-2026 | $21.20B | +7% y/y |
| Diluted EPS · Q3-2026 | $1.63 | +6% y/y |
| Operating Cash Flow · Q3-2026 | $4.00B | |
| Dividends Paid · Q3-2026 | $2.50B | |
| Share Repurchases · Q3-2026 | $600M |
Guidance
Organic Sales Growth: +0% to +4%; Core EPS Growth: +0% to +4%
Maintained FY2026 guidance: organic sales growth 0-4%, core EPS growth 0-4%, adjusted FCF productivity 85-90%, capex 4-5% of sales. Management cites 'challenging macro environment' but sees sequential improvement.
Risks flagged
Tariff cost headwinds and commodity cost increases pressuring margins.
“50 bps tariff cost impact on gross margin; 10 bps commodity cost increase.”
Unfavorable product mix impacting gross margin.
“180 bps unfavorable mix impact on core gross margin.”
24 Apr 202610-QNet Sales $21.23B (+7% y/y); Net Sales (YTD) $65.83B (+4% y/y); Net Earnings $3.95B (+4% y/y)open
Figures in the filing · each found in the filing text
| Net Sales · Q3-2026 | $21.23B | +7% y/y |
| Net Sales (YTD) · 9M-2026 | $65.83B | +4% y/y |
| Net Earnings · Q3-2026 | $3.95B | +4% y/y |
| Net Earnings (YTD) · 9M-2026 | $13.06B | +5% y/y |
| Diluted EPS · Q3-2026 | $1.63 | +6% y/y |
| Core EPS · Q3-2026 | $1.59 | +3% y/y |
| Gross Margin · Q3-2026 | 49.5% | |
| Operating Cash Flow (YTD) · 9M-2026 | $14.40B | +13% y/y |
| Adjusted Free Cash Flow (YTD) · 9M-2026 | $11.70B | |
| Fabric & Home Care Net Sales · Fabric & Home Care · Q3-2026 | $7.40B | +7% y/y |
Risks flagged
Tariff Cost Pressure
“50 basis points of higher costs from tariffs (Q3); 60 basis points of higher tariff costs (YTD)” · word for word
Restructuring Execution Risk
“The Company expects to incur approximately $1.5 to $2.0 billion in before-tax restructuring costs over a two-year period.” · word for word
Unfavorable Product Mix
“180 basis points of decline from unfavorable product mix (Q3); 120 basis points of decline from unfavorable product mix (YTD)” · word for word
Commodity Cost Inflation
“10 basis points of higher commodity costs (Q3); 10 basis points of higher commodity costs (YTD)” · word for word
Foreign Exchange Volatility
“We have significant exposure to exchange rate fluctuations, both due to translation and transaction exposures.” · word for word
23 Jan 202610-QPG reported Q2 FY2026 results with net sales +1%, but gross margin -120bps and EPS -5%, with no explicit beat or miss versus expectations stated in the filing.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q2-2026 | $22.21B | +1% y/y |
| Net Sales · H1-2026 | $44.59B | +2% y/y |
| Net Earnings Attributable to Procter & Gamble · Q2-2026 | $4.32B | -7% y/y |
| Net Earnings Attributable to Procter & Gamble · H1-2026 | $9.07B | +6% y/y |
| Diluted EPS · Q2-2026 | $1.78 | -5% y/y |
| Diluted EPS · H1-2026 | $3.73 | +7% y/y |
| Core EPS · Q2-2026 | $1.88 | 0% y/y |
| Core EPS · H1-2026 | $3.87 | +2% y/y |
| Operating Cash Flow · H1-2026 | $10.40B | |
| Adjusted Free Cash Flow · H1-2026 | $8.70B |
Risks flagged
Tariff cost pressure on margins
“60 basis points of higher costs from tariffs (Q2 gross margin bridge)” · word for word
Restructuring execution risk
“The Company expects to incur approximately $1.5 to $2.0 billion in before-tax restructuring costs over a two-year period.” · word for word
Volume decline in key segments
“Baby, Feminine & Family Care net sales decreased 3% ... driven by a unit volume decline of 5%” · word for word
Foreign exchange volatility
“We have significant exposure to exchange rate fluctuations, both due to translation and transaction exposures.” · word for word
22 Jan 20268-K · 2.02Net sales $22.20B (+1% y/y); Diluted EPS (GAAP) $1.78 (-5% y/y); Core EPS $1.88 (+0% y/y); Guidance: Organic sales +0-4%; core EPS growth +0-4%earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $22.20B | +1% y/y |
| Diluted EPS (GAAP) · Q2-2026 | $1.78 | -5% y/y |
| Core EPS · Q2-2026 | $1.88 | 0% y/y |
| Operating cash flow · Q2-2026 | $5.00B | |
| Adjusted free cash flow productivity · Q2-2026 | 88.0% | |
| Core gross margin change · Q2-2026 | -50.0% | |
| Core operating margin change · Q2-2026 | -70.0% | |
| Dividends returned to shareholders · Q2-2026 | $2.50B | |
| Share repurchases · Q2-2026 | $2.30B |
Guidance
Organic sales +0-4%; core EPS growth +0-4%
Maintained FY guidance ranges despite tariff headwinds, indicating confidence in second-half recovery.
Risks flagged
Tariff headwinds of $0.4bn after-tax are a significant drag on earnings
“Outlooking $0.4bn after-tax headwind from tariffs”
Volume decline of 1% indicates potential consumer demand weakness
“Organic volume declined 1 point”
Core gross margin compression of 50 bps due to tariffs and mix
“Core gross margin decreased 50 basis points”
13 Jan 20268-K · 7.01Quarterly dividend per share $1.06open
Figures in the filing · each found in the filing text
| quarterly dividend per share · Q2-2026 | $1.06 |
15 Dec 20258-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Leadership transition risk in Health Care segment
“retirement of CEO - Health Care”
3 Nov 20258-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
Increased debt load may increase interest expense, but PG has strong credit profile.
“Issuance of €1B and $1.25B in notes.”
24 Oct 202510-QQ1 FY2026 earnings: net sales +3%, organic sales +2%, EPS +21% (Core EPS +3%), gross margin -70bps.earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Total Company · Q1-2026 | $22.39B | +3% y/y |
| Organic Sales Growth · Total Company · Q1-2026 | 2.0% | |
| Diluted EPS · Total Company · Q1-2026 | $1.95 | +21% y/y |
| Core EPS · Total Company · Q1-2026 | $1.99 | +3% y/y |
| Gross Margin · Total Company · Q1-2026 | 51.4% | |
| Operating Cash Flow · Total Company · Q1-2026 | $5.40B | +26% y/y |
Risks flagged
Tariff Cost Pressure
“60 basis points of higher costs from tariffs.” · word for word
Foreign Exchange Risk
“We have significant exposure to exchange rate fluctuations...which have negatively impacted net sales, net earnings and cash flows.” · word for word
Commodity Cost Inflation
“10 basis points of higher commodity costs.” · word for word
24 Oct 20258-K · 2.02Net Sales $22.40B (+3% y/y); Diluted EPS $1.95 (+21% y/y); Core EPS $1.99 (+3% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q1-2026 | $22.40B | +3% y/y |
| Diluted EPS · Q1-2026 | $1.95 | +21% y/y |
| Core EPS · Q1-2026 | $1.99 | +3% y/y |
| Operating Cash Flow · Q1-2026 | $5.40B | |
| Adjusted Free Cash Flow Productivity · Q1-2026 | 102.0% | |
| Core Gross Margin Change · Q1-2026 | -50.0% |
Guidance
P&G maintains FY2026 guidance for sales, EPS, and cash return despite tariff/commodity headwinds.
Risks flagged
Tariff and commodity cost headwinds pressuring gross margin; $0.4bn after-tax tariff headwind and $0.1bn commodity headwind expected for FY2026.
“Outlooking $0.4bn after-tax headwind from tariffs; $0.1bn after-tax headwind from commodities.”
Global market share declining; aggregate value share down 30bps, only 24 of top 50 category/country combos holding or growing share.
“Global aggregate value share is down 30 basis points, with 24 of our top 50 category/country combinations holding or growing share.”
The Procter & Gamble Company — questions
- What did The Procter & Gamble Company file recently?
- 24 SEC filings in the last 12 months. Latest: 10-Q on 2026-10-22 — P&G reported Q1 fiscal 2027 net sales of $23.3B (+4% YoY), diluted EPS of $1.97 (+1%), and gross margin contraction of 160 bps.
Every figure on this page comes from The Procter & Gamble Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.